Companies · Other Health Care

NextGxDx, Inc.

FRANKLIN · Other Health Care

Diligence memoA one-page analyst read on NextGxDx, Inc. — recommendation, valuation, rhythm, risks.
$8.1M
Total raised · real
4
Rounds
1.0×
Latest step-up
Top 29%
Sector rank · raised
Seed
Latest stage · inferred · Mon Aug 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)

NextGxDx, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.82× the median modeled value of Seed Other Health Care companies in 2016–2018 (222 peers) — value vs value, same stage and era.
  • Within the normal band (82% of peer median) for its niche.
Dormant
  • Last raise 9.9 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

NextGxDx, Inc. is one of 5376 Other Health Care companies tracked from FRANKLIN. By capital raised it ranks in the upper tier (ahead of 72% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeed · 2014-02-28 Raised $2.9M (real) Modeled valuation $73M (est)$2.9M$73MSeed2014Seed · 2014-09-30 Raised $2.2M (real) Modeled valuation $55M (est)$2.2M$55MSeed2014Seed · 2015-09-24 Raised $1.5M (real) Modeled valuation $37M (est)$1.5M$37MSeed2015Seed · 2015-09-24 Raised $1.5M (real) Modeled valuation $37M (est)$1.5M$37MSeed2015Seed · 2016-08-22 Raised $1.5M (real) Modeled valuation $37M (est)$1.5M$37MSeed2016+$2.2M+$1.5M+$1.5M+$1.5MCumulative $9.6M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$2.9M · 2014
Seed extension$2.2M · 2014
Seed extension$1.5M · 2015
Seed extension$1.5M · 2015
Seed extension$1.5M · 2016

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$36.5M
Base estimate est.
$1.2M
Conservative case
$286.4M
Upside case
$7.4M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $73.1M · 2014-02-282014Seed · modeled $55.2M · 2014-09-30Seed · modeled $37.2M · 2015-09-24Seed · modeled $37.2M · 2015-09-24Seed · modeled $36.5M · 2016-08-222016
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
6.0 yr
Elapsed time used
9.9 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
7 mo
Avg between rounds
$3.3M/yr
Capital velocity
12.3 yr
On record since
2014
First round
5
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 3.4× above median
This company$8.1M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.9× of median
This company$1.5M
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 1.7× above median
This company$36.5M
Sector median$22.1M

Raised more than 72% of sector peers (real $). Modeled value above 62% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #135 of 222.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0MCapital raised (log)Eye Academy of America Ltd. · Seed Raised $4.0M · modeled $99.1M (est)Guest House Holdings, LLC · Seed Raised $4.0M · modeled $99.1M (est)Cb Therapeutics Inc. · Seed Raised $4.0M · modeled $99.1M (est)Ruddco Inc. · Seed Raised $4.0M · modeled $99.1M (est)Shift Sciences, LLC · Seed Raised $4.0M · modeled $98.6M (est)BHCP OK4 HH/H Investors, LLC · Seed Raised $4.0M · modeled $97.9M (est)ReNovo, Inc. · Seed Raised $4.0M · modeled $97.9M (est)CCRC of Lenexa, LLC · Seed Raised $3.9M · modeled $97.6M (est)Nocira, Llc · Seed Raised $3.9M · modeled $96.7M (est)PureFlowCath, LLC · Seed Raised $3.8M · modeled $94.6M (est)Prevent Biometrics, Inc. · Seed Raised $4.2M · modeled $94.2M (est)Medal, Inc. · Seed Raised $3.8M · modeled $93.6M (est)NextGxDx, Inc. (this company) Raised $8.1M · modeled $36.5M (est)NextGxDx, Inc.
CompanyStageRaised · realValue · estvs peer med.
Eye Academy of America Ltd.Seed$4.0M$99.1M2.23×
Guest House Holdings, LLCSeed$4.0M$99.1M2.23×
Cb Therapeutics Inc.Seed$4.0M$99.1M2.23×
Ruddco Inc.Seed$4.0M$99.1M2.23×
Shift Sciences, LLCSeed$4.0M$98.6M2.22×
BHCP OK4 HH/H Investors, LLCSeed$4.0M$97.9M2.21×
ReNovo, Inc.Seed$4.0M$97.9M2.21×
CCRC of Lenexa, LLCSeed$3.9M$97.6M2.20×
Nocira, LlcSeed$3.9M$96.7M2.18×
PureFlowCath, LLCSeed$3.8M$94.6M2.13×
Prevent Biometrics, Inc.Seed$4.2M$94.2M2.12×
Medal, Inc.Seed$3.8M$93.6M2.11×
NextGxDx, Inc. this companySeed$8.1M$36.5M0.82×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$2.9M2014-02-28$14.7M$73.1M90%
Seed$2.2M2014-09-30$11.1M$55.2M90%
Seed$1.5M2015-09-24$7.5M$37.2M90%
Seed$1.5M2015-09-24$7.5M$37.2M90%
Seed$1.5M2016-08-22$7.4M$36.5M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$2.9M2014-02-28
    • First recorded raise — entered as Seed.
  2. Seed$2.2M2014-09-30
    • Came back fast: 7 mo vs the ~14 mo sector norm.
    • Round 1.3× smaller than the prior — bridge or down round.
  3. Seed$1.5M2015-09-24
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 1.5× smaller than the prior — bridge or down round.
  4. Seed$1.5M2015-09-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  5. Seed$1.5M2016-08-22
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
Intelligence
2017 ~Q2
Modeled next raise · ~7mo cadence
$1.5M
Modeled next size est.range $1.5M$2.4M
1.0×
Last step-up
$3.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Mark Harris5 other2014-02
Chase Perry3 other2015-09
CURT THORNE2 other2015-09
Jim Kever2 other2014-02
Patrick Balthrop2 other2014-02
Philip Hertik2 other2015-09
Robert Metcalf2 other2016-08
George I. Lazenby1 other2014-09
George Lazenby1 other2014-02
Jim D. Kever1 other2014-09
Phil Hertik1 other2014-02
Walter Loewenbaum1 other2014-02
Chase I. Perry2016-08
Curt I. Thorne2016-08
Jim Lackey2014-02
Jim V. Lackey2014-09
Patrick G. Balthrop2014-09
Patrick I. Balthrop2016-08
Philip G. Hertik2014-09
Philip I. Hertik2016-08
Trey G. Noel2014-09
Trey Noel2014-02
Walter G. Loewenbaum2014-09
Will Johnson2015-09
Registry & provenance

NextGxDx, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1602042
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
NeighborMD Management, LLCOther Health CareSeed$2.6M$51.6Mnetwork1 shared operator · same sector · same stage
Spectrascience IncOther Health CareSeed$7.9M$31.0Msame sector · same stage
Penrith CorpOther Health CareSeed$7.8M$37.4Msame sector · same stage
TecTraum, Inc.Other Health CareSeed$7.8M$36.6Msame sector · same stage
Sensory Medical IncOther Health CareSeed$8.8M$37.2Msame sector · same stage
Innovative Biosensors IncOther Health CareSeed$7.2M$37.5Msame sector · same stage
Vital Access CorpOther Health CareSeed$6.9M$37.2Msame sector · same stage
VesOcclude Medical LLCOther Health CareSeed$6.7M$37.6Msame sector · same stage
Frequently asked
How much funding has NextGxDx, Inc. raised?
NextGxDx, Inc. has raised approximately $8.1M in disclosed capital across 4 recorded financing rounds, aggregated from public filings.
What is NextGxDx, Inc.'s estimated valuation?
Provath's modeled valuation for NextGxDx, Inc. is approximately $36.5M (modeled range $1.2M–$286.4M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is NextGxDx, Inc. at?
NextGxDx, Inc.'s latest modeled financing stage is Seed. Its most recent recorded round closed around Mon Aug 22.
What does NextGxDx, Inc. do and where is it based?
NextGxDx, Inc. operates in the Other Health Care sector, based in FRANKLIN.
Explore related

See where NextGxDx, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at NextGxDx, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.